AnalyzeDirect

Bevacizumab enhances the therapeutic efficacy of Irinotecan against human head and neck squamous cell carcinoma xenografts

Cao S, Durrani FA, Toth K, Rustum YM, Seshadri M. Bevacizumab enhances the therapeutic efficacy of Irinotecan against human head and neck squamous cell carcinoma xenografts. Oral Oncol. June 2011;47(6):459-466. Full Text – Open Access Publication Date June 2011 How Analyze was Used “All post processing and analysis were performed using Analyze™ (AnalyzeDirect, Overland Park,…